Abstract：In documenting clinical experience in the diagnosis and treatment of graft versus host disease (GVHD), we retrospectively analyzed data of one case that has developed GVHD after liver transplantation. This patient exhibited fever, skin rash, and diarrhea on day 9 after liver transplantation. His liver function was normal. Skin biopsy showed scattered keratinocytes accompanied by satellite-like lymphocyte infiltration and basal cell liquefaction degeneration. After carefully analyzing the complications, we took the strategy of decreasing the dose of tacrolimus. Thereafter, the patient’s temperature decreased to normal, his skin rashes subsided, and his diarrhea was relieved. This case suggests that reducing the dosage of immunosuppressive agents can be an effective strategy for GVHD after liver transplantation.
. Graft versus host disease after liver transplantation: A case report[J]. Front. Med., 2010, 4(4): 469-472.
Peng-Ji GAO, Xi-Sheng LENG, Dong WANG, Guang-Ming LI, Lei HUANG, Jie GAO, JI-Ye ZHU, . Graft versus host disease after liver transplantation: A case report. Front. Med., 2010, 4(4): 469-472.
Taylor A L, Gibbs P, Bradley J A. Acute graft versus host disease followingliver transplantation: the enemy within. Am J Transplant, 2004, 4(4): 466–474 15023138
Smith D M, Agura E, Netto G, Collins R, Levy M, Goldstein R, Christensen L, Baker J, Altrabulsi B, Osowski L, McCormack J, Fichtel L, Dawson D B, Domiati-Saad R, Stone M, Klintmalm G. Liver transplant-associated graft-versus-host disease. Transplantation, 2003, 75(1): 118–126 12544883
Liang T B, Tang X F, Zheng S S, Lu A W, Wang W L, Shen Y, Zhang M, Meng X Q. Graft versus host disease after livertransplantation: a report of 3 cases. Zhonghua Yi Xue Za Zhi, 2004, 84(10): 826–829 PMID: 15200885
Key T, Taylor C J, Bradley J A, Taylor A L. Recipients who receive a human leukocyte antigen-B compatible cadavericliver allograft are at high risk of developing acute graft-versus-hostdisease. Transplantation, 2004, 78(12): 1809–1811 15614155
Soejima Y, Shimada M, Suehiro T, Hiroshige S, Gondo H, Takami A, Yasue S, Maehara Y. Graft-versus-host diseasefollowing living donor liver transplantation. Liver Transpl, 2004, 10(3): 460–464 15004778
Kolb H J, Guenther W, Gyurkocza B, Hoetzl F, Simoes B, Falk C, Schleuning M, Ledderose G. Tolerance and chimerism. Transplantation, 2003, 75(9 Suppl): 26S–31S 12819487
Schlitt H J, Raddatz G, Steinhoff G, Wonigeit K, Pichlmayr R. Passenger lymphocytes in human liver allografts and their potentialrole after transplantation. Transplantation, 1993, 56(4): 951–955 8105572
Kleeberger W, Roth?mel T, Gl?ckner S, Lehmann U, Kreipe H. Laser-assisted microdissection and short tandem repeat PCR for the investigationof graft chimerism after solid organ transplantation. Pathobiology, 2000, 68(4―5): 196–201 11279346
Lehner F, Becker T, Sybrecht L, Lück R, Schwinzer R, Slateva K, Blasczyk R, Hertenstein B, Klempnauer J, Nashan B. Successful outcome of acute graft-versus-host disease in a liver allograft recipientby withdrawal of immunosuppression. Transplantation, 2002, 73(2): 307–310 PMID: doi: 10.1097/00007890-200201270-00030 11821752 doi: 10.1097/00007890-200201270-00030
Lu Y, Wu L Q, Zhang B Y, Cao J Y. Graft-versus-host disease after liver transplantation: successfultreatment of a case. Transplant Proc, 2008, 40(10): 3784–3786 19100490
Wisecarver J L, Cattral M S, Langnas A N, Shaw B W Jr, Fox I J, Heffron T G, Rubocki R J. Transfusion-induced graft-versus-host disease after liver transplantation.Documentation using polymerase chain reaction with HLA-DR sequence-specificprimers. Transplantation, 1994, 58(3): 269–271 doi: 8053046
